Antibody‐Conjugated Magnetic Nanoparticle Therapy for Inhibiting T‐Cell Mediated Inflammation
Abstract Tolerance induction is critical for mitigating T cell‐mediated inflammation. Treatments based on anti‐CD3 monoclonal antibody (mAb) play a pivotal role in inducing such tolerance. Anti‐CD3 mAb conjugated with dextran‐coated magnetic nanoparticles (MNPs) may induce inflammatory tolerance is...
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Wiley
2024-03-01
|
| Sraith: | Advanced Science |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1002/advs.202307148 |